Pharmafile Logo
Pharmafocus logo
Advanced Search

court

Showing 12 posts of 12 posts found.

AstraZeneca vs GSK: Cancer drug court battle could cost hundreds of millions

June 7, 2021
Sales and Marketing AstraZeneca, GSK, court

AstraZeneca has launched a court case against Glaxo Smith Kline (GSK), in a claim that could reach hundreds of millions …

News
amgen_flag

Court sides with Amgen in Sandoz’ challenge over patent on Enbrel

August 12, 2019
Sales and Marketing Enbrel, IP, Novartis Amgen, court, patent, pharma

A US court has sided with Amgen in a legal battle over the patent on blockbuster rheumatoid arthritis drug Enbrel. …

News

US Judge blocks Trump administration law requiring pharma to include prices in TV ads

July 9, 2019
Manufacturing and Production Amgen, Eli Lilly, MSD, TV ads, Trump, USA, court, pharma

A judge has blocked the Trump administration from enacting a law that would require pharmaceutical companies to include the prices …

News
facilities_lg06

Dr Reddy’s demand more than $70 million from Indivior over generic Suboxone Film

March 12, 2019
Manufacturing and Production Dr Reddy's, Suboxone Film, court, indivior, opioid addiction

Indian firm Dr Reddy’s is seeking at least $70 million from British firm Indivior Plc as compensation for lost sales …

News

Teva settles $135 million dollar fraud case over Medicaid price inflation

January 14, 2019
Sales and Marketing court, fraud, law, lawsuit, pharma, price fxing

Israeli multinational Teva Pharmaceuticals has agreed to pay $135 million after being accused of fraudulently inflating wholesale prices that went …

News
bad_homburg_fresenius_zentrale

Akorn CEO resigns after $4.3bn Fresenius deal falls through

December 10, 2018
Sales and Marketing Akorn, CEO, Fresenius, M&A, MA, Raj Rai, court, generics

The CEO of American generics firm Akorn Inc has stepped down following a ruling from the Delaware Supreme Court declaring …

News

Pfizer defeated in Britain’s highest court over Lyrica patent

November 15, 2018
Business Services, Medical Communications Legislation, Lyrica, Pfizer, court, pharma

American pharma firm Pfizer have lost in the final round of a protracted court battle over the patent on epilepsy …

News
abbvie_0

AbbVie sue NHS over hepatitis C drug procurement

November 8, 2018
Business Services AbbVie, NHS, britain, court, hep C, hepatitis, ruling

American pharma firm AbbVie are suing Britain’s NHS after claiming that the health service’s procurement of hepatitis C drugs breached …

News

US court overturns J&J’s Zytiga patent in combination with prednisone

October 29, 2018
Sales and Marketing J&J, JJ, Johnson and Johnson, Zytiga, court, generic, prednisone

A court in New Jersey has invalidated Johnson & Johnson’s patent on the prostate cancer drug Zytiga when used in …

News
Canary Wharf European Medicines Agency

Landlord demands EMA pay £500m for Canary Wharf lease

July 27, 2018
Medical Communications Canary Wharf, EMA, Litigation, London, amsterdam, court

A British landlord is taking the European Medicines Agency (EMA) to court over a £500 million bill for unpaid rent. …

News

Alvogen court case causes Nevada Judge to halt execution

July 13, 2018
Medical Communications Alvogen, Nevada, court, execution, lethal injection

A Nevada Judge has temporarily prevented the use of the sedative midazolam, in the execution of the twice convicted killer …

News
gavel

Baxalta sues Chugai for haemophilia drug patent breach

May 11, 2016
Research and Development Baxalta, Chugai, breach, court, haemophilia, infringe, infringement, patent, sue, suing

Baxalta has taken Chugai Pharmaceuticals to the Tokyo district court, claiming that the Japanese company has infringed upon its patent …

News

Latest content

Ardena announces €20m expansion following first GMP approval

April 19, 2024

Roche’s Alecensa approved by FDA as lung cancer treatment

April 19, 2024

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024